|
|
||||||||
Cardiology Section, Department of Medicine, Veterans Affairs, San Diego Healthcare System, and University of California, San Diego, San Diego, California 92161
Lipopolysaccharide (LPS)
from gram-negative bacteria circulates in acute, subacute, and
chronic conditions. It was hypothesized that LPS directly induces
cardiac apoptosis. In adult rat ventricular myocytes (isolated
with depyrogenated digestive enzymes to minimize tolerance), LPS (10 ng/ml) decreased the ratio of Bcl-2 to Bax at 12 h; increased
caspase-3 activity at 16 h; and increased annexin V, propidium
iodide, and terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling staining at 24 h. Apoptosis was blocked by
the caspase inhibitor benzyloxycarbonyl-valine-alanine-aspartate fluoromethylketone (Z-VAD-fmk), captopril, and angiotensin II type
1 receptor (AT1) inhibitor (losartan), but not by
inhibitors of AT2 receptors (PD-123319), tumor necrosis
factor-
(TNFRII:Fc), or nitric oxide
(NG-monomethyl-L-arginine).
Angiotensin II (100 nmol/l) induced apoptosis similar to LPS
without additive effects. LPS in vivo (1 mg/kg iv) increased
apoptosis in left ventricular myocytes for 1-3 days, which
dissipated after 1-2 wk. Losartan (23 mg · kg
1 · day
1 in drinking
water for 3 days) blocked LPS-induced in vivo apoptosis. In
conclusion, low levels of LPS induce cardiac apoptosis in vitro and in vivo by activating AT1 receptors in myocytes.
endotoxemia; programmed cell death; cardiac renin-angiotensin; angiotensin II
This article has been cited by other articles:
![]() |
S. Telemaque and J. L. Mehta Sepsis, Calcineurin, and Cardiac Dysfunction: The Saga of Life and Death J. Am. Coll. Cardiol., January 30, 2007; 49(4): 500 - 501. [Full Text] [PDF] |
||||
![]() |
J. Suzuki, E. Bayna, H. L. Li, E. D. Molle, and W. Y.W. Lew Lipopolysaccharide Activates Calcineurin in Ventricular Myocytes J. Am. Coll. Cardiol., January 30, 2007; 49(4): 491 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimojo, S. Jesmin, S. Zaedi, M. Soma, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid. Experimental Biology and Medicine, June 1, 2006; 231(6): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. W. Lew Endotoxin attacks the cardiovascular system: Black death at the tollgate J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1663 - 1665. [Full Text] [PDF] |
||||
![]() |
J. Suzuki, E. Bayna, E. Dalle Molle, and W. Y. W. Lew Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats J. Am. Coll. Cardiol., February 5, 2003; 41(3): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |